NIH-funded research R21 grant

Investigating how glucocorticoid receptors affect alcohol dependence

Official title: Role of glucocorticoid receptor-mediated mRNA decay in alcohol dependence

Funded at Scripps Research Institute, the · NIH-10931639 · Data updated 2026-11-12

This study is looking at how blocking certain receptors in the brain might help people who struggle with alcohol dependence by reducing their cravings and drinking, and it’s aimed at finding better ways to treat alcohol use disorders.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 20, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$218,040
NIH project number5R21AA030807-02
Project IDNIH-10931639 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of alcohol use disorder who are currently abstinent or undergoing withdrawal.

Less likely to help

Patients who do not have alcohol use disorder or are not experiencing withdrawal symptoms may not benefit from this research.

What this research studies

This research explores the role of glucocorticoid receptors in alcohol dependence, focusing on how their inhibition can reduce alcohol intake and cravings. The study will examine the molecular mechanisms behind this effect, particularly the process of glucocorticoid receptor-mediated mRNA decay, which may influence alcohol consumption behaviors. By analyzing brain samples from mice, the researchers aim to identify specific mRNAs affected by glucocorticoid receptor activity during alcohol withdrawal. This could lead to a better understanding of how to treat alcohol use disorders effectively.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating alcohol dependence.

How similar studies have gone: Previous studies have shown that glucocorticoid receptor inhibition can effectively reduce alcohol intake, suggesting that this approach has potential for success.

Where this research is happening

  • Scripps Research Institute, the
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Contet, Candice — Scripps Research Institute, the
  • Study coordinator: Contet, Candice

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.